[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@vjhemonc Avatar](https://lunarcrush.com/gi/w:26/cr:youtube::UCsQXL4_zTA-FoG9RA1tEGiw.png) @vjhemonc VJHemOnc – Video Journal of Hematology & HemOnc

VJHemOnc – Video Journal of Hematology & HemOnc posts on YouTube about nct, university of, fl, dana the most. They currently have XXXXXX followers and 3679 posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/youtube::UCsQXL4_zTA-FoG9RA1tEGiw/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:youtube::UCsQXL4_zTA-FoG9RA1tEGiw/c:line/m:interactions.svg)

- X Week XXXXX +3,355%
- X Month XXXXX +64%
- X Months XXXXXX -XXXX%
- X Year XXXXXX +25%

### Mentions: XX [#](/creator/youtube::UCsQXL4_zTA-FoG9RA1tEGiw/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:youtube::UCsQXL4_zTA-FoG9RA1tEGiw/c:line/m:posts_active.svg)

- X Months XXX +0.93%
- X Year XXXXX +299%

### Followers: XXXXXX [#](/creator/youtube::UCsQXL4_zTA-FoG9RA1tEGiw/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:youtube::UCsQXL4_zTA-FoG9RA1tEGiw/c:line/m:followers.svg)

- X Week XXXXXX +0.60%
- X Month XXXXXX +1.20%
- X Months XXXXXX +7.70%
- X Year XXXXXX +17%

### CreatorRank: XXXXXXXXX [#](/creator/youtube::UCsQXL4_zTA-FoG9RA1tEGiw/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:youtube::UCsQXL4_zTA-FoG9RA1tEGiw/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[countries](/list/countries)  [travel destinations](/list/travel-destinations)  [finance](/list/finance)  [technology brands](/list/technology-brands)  [luxury brands](/list/luxury-brands)  [cryptocurrencies](/list/cryptocurrencies) 

**Social topic influence**
[nct](/topic/nct) #693, [university of](/topic/university-of) #1276, [fl](/topic/fl) #8, [dana](/topic/dana) #499, [ash](/topic/ash) #863, [stem](/topic/stem) #1169, [italy](/topic/italy), [health](/topic/health), [london](/topic/london), [education](/topic/education)

**Top accounts mentioned or mentioned by**
[@mskccorg](/creator/undefined)

**Top assets mentioned**
[Frontline Ltd. (FRO)](/topic/$fro)
### Top Social Posts
Top posts by engagements in the last XX hours

"The PRISM score: improving risk stratification of newly diagnosed AML treated with ven-based therapy"  
[YouTube Link](https://youtube.com/watch?v=XQK8DwCwjEc)  2025-12-12T14:44Z 16.7K followers, XX engagements


"Practice-changing abstracts from ASH 2025 for community oncologists treating NHL and CLL"  
[YouTube Link](https://youtube.com/watch?v=VtzZlsgjQWM)  2025-12-12T15:15Z 16.7K followers, XX engagements


"HRQoL in patients with transplant-eligible newly diagnosed myeloma treated with Isa-RVd vs Rvd alone"  
[YouTube Link](https://youtube.com/watch?v=nSVO-ZGL81U)  2025-12-12T12:15Z 16.7K followers, X engagements


"Improving CAR T-cell therapy referral patterns of patients with R/R LBCL in the US"  
[YouTube Link](https://youtube.com/watch?v=8UPQTrrP-QI)  2025-12-11T14:31Z 16.7K followers, XX engagements


"Highlights in sickle cell disease from ASH 2025: hydroxyurea in pregnancy gene editing and more"  
[YouTube Link](https://youtube.com/watch?v=IqMTcFDghfo)  2025-12-12T14:13Z 16.7K followers, XX engagements


"Updated efficacy and safety results of BTK degrader BGB-16673 in R/R CLL: the CaDAnCe-101study"  
[YouTube Link](https://youtube.com/watch?v=NCIYqtRsbQc)  2025-12-11T10:19Z 16.7K followers, XX engagements


"Quality improvement initiative to optimize AE management for bispecifics for DLBCL in the community"  
[YouTube Link](https://youtube.com/watch?v=tS1-TlHuIlA)  2025-12-11T14:43Z 16.7K followers, XX engagements


"IFM2021-01 trial Cohort A: teclistamab + daratumumab in older patients with newly diagnosed myeloma"  
[YouTube Link](https://youtube.com/watch?v=-K9_Q88T78A)  2025-12-11T12:49Z 16.7K followers, XX engagements


"Mutation-guided finite-duration AV after first-line BTKi+ven-based therapy in CLL/SLL: MAVRiC trial"  
[YouTube Link](https://youtube.com/watch?v=tcH6kFGzHpI)  2025-12-11T14:20Z 16.7K followers, XX engagements


"Phase I trial of LY4152199 a BAFF-R-targeting bispecific in previously treated B-cell malignancies"  
[YouTube Link](https://youtube.com/watch?v=1RRmJZgGYJg)  2025-12-11T11:21Z 16.7K followers, XX engagements


"Correlation between IL-8 and TNF-alpha levels and OS in patients with R/R MF treated with imetelstat"  
[YouTube Link](https://youtube.com/watch?v=H2PtABSy54o)  2025-12-11T10:52Z 16.7K followers, XX engagements


"Luspatercept initiated at the maximum-approved dose in transfusion-dependent LR-MDS: MAXILUS trial"  
[YouTube Link](https://youtube.com/watch?v=TWhvk-5WvYA)  2025-12-11T10:40Z 16.7K followers, XX engagements


"IMMUNOPLANT: linvoseltamab immuno-consolidation to drive MRD negativity in newly diagnosed myeloma"  
[YouTube Link](https://youtube.com/watch?v=tffDeXWCg0g)  2025-12-12T11:57Z 16.7K followers, XX engagements


"Toxicity outcomes and healthcare utilization related to outpatient blinatumomab for ALL"  
[YouTube Link](https://youtube.com/watch?v=1bG6xpanKJg)  2025-12-10T10:49Z 16.7K followers, XX engagements


"Strategies to enhance patient education and support for transplant and CAR-T therapies"  
[YouTube Link](https://youtube.com/watch?v=2uqjbcSz538)  2025-12-09T08:00Z 16.7K followers, XXX engagements


"Phase II study of burixafor + propranolol + G-CSF for stem cell mobilization in myeloma"  
[YouTube Link](https://youtube.com/watch?v=4Foy0CBLw5Q)  2025-12-10T14:49Z 16.7K followers, XX engagements


"Monitoring for and managing CLS in patients with BPDCN treated with tagraxofusp-based regimens"  
[YouTube Link](https://youtube.com/watch?v=78DvYCbSmfM)  2025-12-10T16:52Z 16.7K followers, XX engagements


"Pirtobrutinib enhances T-cell anti-tumor immunity in CLL"  
[YouTube Link](https://youtube.com/watch?v=7KbZYnA1NF4)  2025-12-08T10:42Z 16.7K followers, XX engagements


"A real-world analysis of the outcomes of patients with PNH treated with iptacopan"  
[YouTube Link](https://youtube.com/watch?v=9uT1-V1dVc8)  2025-12-10T10:11Z 16.7K followers, XX engagements


"First-in-human Phase I results of a novel BTK inhibitor rocbrutinib in R/R CLL"  
[YouTube Link](https://youtube.com/watch?v=A8JwGmqNRLA)  2025-12-11T17:11Z 16.7K followers, XX engagements


"AutoSCT versus consolidation chemotherapy as post-remission treatment in newly diagnosed AML"  
[YouTube Link](https://youtube.com/watch?v=ARw4K6p93tg)  2025-12-09T14:03Z 16.7K followers, XXX engagements


"Biomarkers in ITP: understanding a patient's immune phenotype and guiding therapeutic selection"  
[YouTube Link](https://youtube.com/watch?v=Ac49WY4NqME)  2025-12-09T16:44Z 16.7K followers, XX engagements


"Phase Ib trial of ivosidenib plus ruxolitinib in IDH1-mutated advanced MPNs"  
[YouTube Link](https://youtube.com/watch?v=AhqSaxrtw6U)  2025-12-09T17:00Z 16.7K followers, XX engagements


"Updated results with the bispecific antibody etentamig in patients with R/R AL amyloidosis"  
[YouTube Link](https://youtube.com/watch?v=AxcqqTGLcG0)  2025-12-10T16:21Z 16.7K followers, XX engagements


"Phase I trial of CLN-049 a novel anti-FLT3 x anti-CD3 bispecific T-cell engager in R/R AML"  
[YouTube Link](https://youtube.com/watch?v=CPjLgGFvsr4)  2025-12-10T15:33Z 16.7K followers, XX engagements


"Correlation between treatment-emergent cytopenias and clinical response with imetelstat in LR-MDS"  
[YouTube Link](https://youtube.com/watch?v=EaA8WF4q2LE)  2025-12-11T11:06Z 16.7K followers, XX engagements


"Expanding CAR-T therapy to smaller centers to meet rising demand"  
[YouTube Link](https://youtube.com/watch?v=EkDyclF4aDg)  2025-12-10T14:35Z 16.7K followers, XX engagements


"Updated results from KOMET-007: ziftomenib plus aza-ven in R/R NPM1-m or KMT2A-r AML"  
[YouTube Link](https://youtube.com/watch?v=HqCzlLN6yJ4)  2025-12-09T10:55Z 16.7K followers, XX engagements


"Implementing bispecific antibody therapy for R/R myeloma and lymphoma in an institution in the UK"  
[YouTube Link](https://youtube.com/watch?v=Hxb6xwVMVkY)  2025-12-10T14:41Z 16.7K followers, XX engagements


"Crenolanib plus salvage chemotherapy in FLT3-mutant R/R AML: results from a randomized trial"  
[YouTube Link](https://youtube.com/watch?v=IBSxVbXK2YA)  2025-12-12T11:43Z 16.7K followers, XX engagements


"Diagnostic evaluation methods and prognostic impact of FLT3-ITD microclones in AML"  
[YouTube Link](https://youtube.com/watch?v=JKl229eKmPU)  2025-12-10T13:26Z 16.7K followers, XX engagements


"Bispecific antibodies in myeloma: top trial updates from ASH 2025"  
[YouTube Link](https://youtube.com/watch?v=JPS-qqo0g7Y)  2025-12-10T17:18Z 16.7K followers, XXX engagements


"Interpreting findings from the VERONA trial in MDS: factors influencing the lack of survival benefit"  
[YouTube Link](https://youtube.com/watch?v=JsOei7EBpa4)  2025-12-10T10:34Z 16.7K followers, XX engagements


"HMA maintenance therapy in TP53-mutated AML and MDS improves outcomes of transplantation"  
[YouTube Link](https://youtube.com/watch?v=Kmn2PF4FQFU)  2025-12-10T11:49Z 16.7K followers, XX engagements


"An upcoming Phase II trial of eltrombopag in low-risk MDS and CMML harboring TET2 mutations"  
[YouTube Link](https://youtube.com/watch?v=L0q6DSpfBR0)  2025-12-10T14:26Z 16.7K followers, XX engagements


"Cardiac safety of two Dara-VCd dosing schedules in newly diagnosed AL amyloidosis: AQUARIUS trial"  
[YouTube Link](https://youtube.com/watch?v=L2Kr95ldMxI)  2025-12-09T17:31Z 16.7K followers, XX engagements


"A novel CAR T-cell therapy targeting the intracellular protein MZB1 for multiple myeloma"  
[YouTube Link](https://youtube.com/watch?v=LDWJi3qkGNg)  2025-12-10T11:17Z 16.7K followers, XX engagements


"TaZa CLL: tafasitamab and zanubrutinib in newly diagnosed CLL"  
[YouTube Link](https://youtube.com/watch?v=LlSM8kGmXLE)  2025-12-10T10:47Z 16.7K followers, XX engagements


"Key agents of interest in the AL amyloidosis space with trial updates presented at ASH 2025"  
[YouTube Link](https://youtube.com/watch?v=MOXYwh7Vz1c)  2025-12-09T16:57Z 16.7K followers, XX engagements


"Outcomes with low-intensity venetoclax in NPM1-mutated AML depend on co-mutational profile"  
[YouTube Link](https://youtube.com/watch?v=MVcdKIyJ2Ss)  2025-12-10T14:52Z 16.7K followers, XX engagements


"Real-world treatment duration of ruxolitinib and transfusion use in patients with myelofibrosis"  
[YouTube Link](https://youtube.com/watch?v=QXmBykuMMJc)  2025-12-09T17:49Z 16.7K followers, XX engagements


"Fixed-duration and MRD-adapted therapy in CLL: insights from ASH 2025"  
[YouTube Link](https://youtube.com/watch?v=R-NGPiKgkNA)  2025-12-11T16:23Z 16.7K followers, XX engagements


"huCART19-IL18 in patients with CLL/SLL or RT after prior BTK inhibitor and venetoclax exposure"  
[YouTube Link](https://youtube.com/watch?v=RBjsOaqj6ec)  2025-12-09T12:57Z 16.7K followers, XX engagements


"Final report of a Phase II study of venetoclax and ibrutinib in previously untreated WM"  
[YouTube Link](https://youtube.com/watch?v=U01tqO3PctA)  2025-12-11T16:22Z 16.7K followers, XX engagements


"Pirtobrutinib versus ibrutinib in treatment-nave and R/R CLL: findings from BRUIN-CLL-314"  
[YouTube Link](https://youtube.com/watch?v=V6vdGb3Fl84)  2025-12-11T16:59Z 16.7K followers, XX engagements


"Results of a Phase II trial of pirtobrutinib plus venetoclax in previously treated WM"  
[YouTube Link](https://youtube.com/watch?v=VBhM5qSjnYY)  2025-12-11T16:36Z 16.7K followers, XX engagements


"Three-year follow-up from S1826: immunotherapy plus combination chemotherapy in stage III-IV cHL"  
[YouTube Link](https://youtube.com/watch?v=VwaI42USNJY)  2025-12-09T15:22Z 16.7K followers, XX engagements


"ReKInDLE: a Phase II trial of iberdomide carfilzomib daratumumab & dexamethasone for R/R myeloma"  
[YouTube Link](https://youtube.com/watch?v=WQI0sKHNJYY)  2025-12-10T13:08Z 16.7K followers, XX engagements


"Early analysis of ODYSSEY: momelotinib plus luspatercept in transfusion-dependent myelofibrosis"  
[YouTube Link](https://youtube.com/watch?v=WYDZrDFHl2E)  2025-12-09T16:14Z 16.7K followers, XX engagements


"Preliminary results with the LSD1 inhibitor iadademstat combined with aza-ven in newly diagnosed AML"  
[YouTube Link](https://youtube.com/watch?v=WtBxrNZsT38)  2025-12-10T17:41Z 16.7K followers, XX engagements


"Developing and testing a tandem CD19/ROR1 CAR-NK to overcome apoptotic resistance in CLL"  
[YouTube Link](https://youtube.com/watch?v=YEZC2I7-M04)  2025-12-12T15:23Z 16.7K followers, XX engagements


"Real-world outcomes of varnimcabtagene autoleucel in B-cell lymphoma and toxicity challenges"  
[YouTube Link](https://youtube.com/watch?v=ZvtFxPixcf0)  2025-12-09T18:00Z 16.7K followers, XX engagements


"The prognostic impact of KMT2A fusion transcript detection in patients with KMT2A-r AML in CR1"  
[YouTube Link](https://youtube.com/watch?v=_um_Td6816o)  2025-12-10T13:44Z 16.7K followers, XX engagements


"ASC4OPT: asciminib in two dosing schedules in patients with CML resistant or intolerant to 2+ TKIs"  
[YouTube Link](https://youtube.com/watch?v=aI3e_jK-9jc)  2025-12-10T11:54Z 16.7K followers, XX engagements


"A Phase II decentralized clinical trial of ivosidenib in IDH1-mutated CCUS"  
[YouTube Link](https://youtube.com/watch?v=coIje5xwAMY)  2025-12-10T14:18Z 16.7K followers, XX engagements


"An update on the ENERGIZE-T trial of mitapivat in transfusion-dependent thalassemia"  
[YouTube Link](https://youtube.com/watch?v=dOGqAYfWeAI)  2025-12-10T11:37Z 16.7K followers, XX engagements


"Building a framework for advanced multiple myeloma care in Kenya: outcomes of the 2024 workshop"  
[YouTube Link](https://youtube.com/watch?v=e-NO0BgMTbQ)  2025-12-09T14:53Z 16.7K followers, XX engagements


"In vivo CAR-T for multiple myeloma: promising findings from a small trial"  
[YouTube Link](https://youtube.com/watch?v=egW5RWSJU0Y)  2025-12-10T08:00Z 16.7K followers, XX engagements


"Replacing standard FISH panels with WGS in multiple myeloma"  
[YouTube Link](https://youtube.com/watch?v=iPeKt5SBRm0)  2025-12-10T11:08Z 16.7K followers, XX engagements


"Three-year follow-up of a Phase Ib trial of mosunetuzumab plus polatuzumab vedotin in R/R DLBCL"  
[YouTube Link](https://youtube.com/watch?v=jxMFqWGVbuo)  2025-12-11T15:58Z 16.7K followers, XX engagements


"Long-term follow-up of TRANSFORM: liso-cel versus SOC for R/R LBCL"  
[YouTube Link](https://youtube.com/watch?v=m_xONmkf4jU)  2025-12-11T15:49Z 16.7K followers, XX engagements


"TAG-AZA-VEN triplet therapy in patients with BPDCN: results of a Phase II trial"  
[YouTube Link](https://youtube.com/watch?v=nbwqgfsAsAE)  2025-12-10T12:21Z 16.7K followers, XX engagements


"Long-term survival results from COMMANDS: luspatercept versus EPO in LR-MDS"  
[YouTube Link](https://youtube.com/watch?v=oMUrScEknlw)  2025-12-10T15:11Z 16.7K followers, XX engagements


"Datasets at ASH 2025 that will refine the management of FLT3-mutated AML"  
[YouTube Link](https://youtube.com/watch?v=pZ1LCjC5DYY)  2025-12-10T08:01Z 16.7K followers, XX engagements


"Mechanisms of resistance to TKIs in CML"  
[YouTube Link](https://youtube.com/watch?v=phmDZe0gHLg)  2025-12-10T09:24Z 16.7K followers, XX engagements


"Approaching treatment decisions in newly diagnosed BPDCN"  
[YouTube Link](https://youtube.com/watch?v=rnaLZtEBM40)  2025-12-10T12:32Z 16.7K followers, XX engagements


"Reni-cel in severe SCD: updated results from the RUBY trial"  
[YouTube Link](https://youtube.com/watch?v=rvjDkgguWsI)  2025-12-10T16:46Z 16.7K followers, XX engagements


"Oral decitabine plus venetoclax for older unfit patients with AML: results of a Phase II study"  
[YouTube Link](https://youtube.com/watch?v=uj236AC9SL4)  2025-12-11T08:30Z 16.7K followers, XX engagements


"Correlation between treatment-emergent cytopenias and clinical response with imetelstat in LR-MDS"  
[YouTube Link](https://youtube.com/watch?v=xs0RO9F06ME)  2025-12-12T10:06Z 16.7K followers, XX engagements


"Key debates in MDS at ASH 2025: diagnosis pre-disease therapy & more"  
[YouTube Link](https://youtube.com/watch?v=yAZBLYbZIfw)  2025-12-10T15:04Z 16.7K followers, XX engagements


"Identifying early signs of amyloidosis: increasing awareness education & improving diagnoses"  
[YouTube Link](https://youtube.com/watch?v=yzsPBjV6dMM)  2025-01-14T15:52Z 16.7K followers, 1060 engagements